AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Daniel Griffin
OA shifts to mainstream with BioMed deal
Daniel Griffin
The acquisition of open access (OA) science publisher BioMed Central by the world's second largest STM publisher Springer could mark the transformation of OA into a mainstream publishing model.
BioMed Central publisher Matthew Cockerill said: "Springer is absolutely committed to maintaining BioMed Central's policy of full open access to all research, and this acquisition is great news for open access."
Springer CEO Derk Haank said: "This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade."
Former chief executive of the BMJ Publishing Group Richard Smith said: "At the moment, fewer than 10% of scientific articles are published open access, but Springer's acquisition may bring us to the tipping point where ...
Source: HighBeam Research, OA shifts to mainstream with BioMed deal.(on Springer's acquisition...